Viyash Scientific Limited (BSE: 512529)
Health Care · Pharmaceuticals · IN
Rs276.25
+8.08% today · +58.2% 1Y
Viyash Scientific Limited (BSE: 512529) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.26B.
Over the last twelve months the share price has gained 58.2%, trading between 167.50 and 297.90.
Tweenvest scores Viyash Scientific Limited across four factors: quality 70/100, value 50/100, growth 85/100. Its strongest factor is growth.
512529 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.26B
- Revenue (TTM)
- $378.10M
- P/E
- 58.19
- EPS
- 4.75
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- Rs297.90
- 52-week low
- Rs167.50
- Avg volume (3M)
- —
- Shares outstanding
- 436.46M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,234.92 | +0.10% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.25 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.27 | -0.12% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.70 | -0.03% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.52 | -0.99% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.